Trilogy Capital’s Crocs CROX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.25M Sell
19,181
-600
-3% -$75.7K 0.09% 153
2026
Q2
$2.39M Buy
+19,781
New +$2.16M 0.09% 149
2026
Q1
– Sell
-6,335
Closed -$542K – 395
2025
Q4
$542K Buy
6,335
+2,450
+63% +$205K 0.02% 240
2025
Q3
$325K Buy
+3,885
New +$355K 0.02% 301

Other funds holding CROX

Trilogy Capital's CROX Position: Q3 2026 in Review

Trilogy Capital reduced its Crocs (CROX) stake by 3% in Q3 2026, selling an estimated $75.7K and leaving 19,181 shares worth $2.25M. The position accounts for 0.09% of the portfolio, ranked #153.

Trilogy Capital first reported a position in CROX in Q3 2025 and has held it in 4 quarters since. The position peaked at $2.39M in Q2 2026. 78 funds tracked by Wall St. Rank hold CROX as of Q3 2026.

  • Trilogy Capital held 19,181 shares of Crocs worth $2.25M as of Q3 2026.
  • Trilogy Capital sold 600 Crocs shares in Q3 2026, an estimated $75.7K.
  • Crocs made up 0.09% of Trilogy Capital's portfolio in Q3 2026, its #153 holding.
  • Trilogy Capital first reported a position in Crocs in Q3 2025 and has held it in 4 quarters since.
  • Trilogy Capital's Crocs position peaked at $2.39M in Q2 2026.
  • 78 funds tracked by Wall St. Rank held Crocs as of Q3 2026.

Based on Trilogy Capital's 13F filing for Q3 2026, filed 20 Oct 2026.